BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1526083)

  • 1. Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity.
    Watkins PB; Turgeon DK; Saenger P; Lown KS; Kolars JC; Hamilton T; Fishman K; Guzelian PS; Voorhees JJ
    Clin Pharmacol Ther; 1992 Sep; 52(3):265-73. PubMed ID: 1526083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease.
    Lown K; Kolars J; Turgeon K; Merion R; Wrighton SA; Watkins PB
    Clin Pharmacol Ther; 1992 Mar; 51(3):229-38. PubMed ID: 1544283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients.
    Schmidt LE; Olsen AK; Stentoft K; Rasmussen A; Kirkegaard P; Dalhoff K
    Clin Pharmacol Ther; 2001 Nov; 70(5):446-54. PubMed ID: 11719731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between postoperative erythromycin breath test and early morbidity in liver transplant recipients.
    Schmidt LE; Rasmussen A; Kirkegaard P; Dalhoff K
    Transplantation; 2003 Jul; 76(2):358-63. PubMed ID: 12883193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 3A4 and P-glycoprotein mediate the interaction between an oral erythromycin breath test and rifampin.
    Paine MF; Wagner DA; Hoffmaster KA; Watkins PB
    Clin Pharmacol Ther; 2002 Nov; 72(5):524-35. PubMed ID: 12426516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythromycin breath test predicts oral clearance of cyclosporine in kidney transplant recipients.
    Turgeon DK; Normolle DP; Leichtman AB; Annesley TM; Smith DE; Watkins PB
    Clin Pharmacol Ther; 1992 Nov; 52(5):471-8. PubMed ID: 1424421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of cytochrome P-450IIIA activity in determining dosage and blood levels of FK 506 and cyclosporine in liver transplant recipients.
    Cakaloglu Y; Tredger JM; Devlin J; Williams R
    Hepatology; 1994 Aug; 20(2):309-16. PubMed ID: 7519161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin breath test and clinical transplantation.
    Watkins PB
    Ther Drug Monit; 1996 Aug; 18(4):368-71. PubMed ID: 8857552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men.
    Kinirons MT; O'Shea D; Downing TE; Fitzwilliam AT; Joellenbeck L; Groopman JD; Wilkinson GR; Wood AJ
    Clin Pharmacol Ther; 1993 Dec; 54(6):621-9. PubMed ID: 8275617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization.
    Chiou WL; Jeong HY; Wu TC; Ma C
    Clin Pharmacol Ther; 2001 Oct; 70(4):305-10. PubMed ID: 11673745
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A.
    Kinirons MT; O'Shea D; Kim RB; Groopman JD; Thummel KE; Wood AJ; Wilkinson GR
    Clin Pharmacol Ther; 1999 Sep; 66(3):224-31. PubMed ID: 10511057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the dapsone recovery ratio and the erythromycin breath test as in vivo probes of CYP3A activity in patients with rheumatoid arthritis receiving cyclosporine.
    Stein CM; Kinirons MT; Pincus T; Wilkinson GR; Wood AJ
    Clin Pharmacol Ther; 1996 Jan; 59(1):47-51. PubMed ID: 8549033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic cytochrome P-4503A (CYP3A) activity in the elderly.
    Hunt CM; Westerkam WR; Stave GM; Wilson JA
    Mech Ageing Dev; 1992 Jun; 64(1-2):189-99. PubMed ID: 1630156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mdr1 limits CYP3A metabolism in vivo.
    Lan LB; Dalton JT; Schuetz EG
    Mol Pharmacol; 2000 Oct; 58(4):863-9. PubMed ID: 10999959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ketoconazole on the erythromycin breath test and the dapsone recovery ratio.
    Kinirons MT; Krivoruk Y; Wilkinson GR; Wood AJ
    Br J Clin Pharmacol; 1999 Feb; 47(2):223-5. PubMed ID: 10190659
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of grapefruit juice on urinary 6 beta-hydroxycortisol/cortisol excretion.
    SeidegÄrd J; Dahlström K; Kullberg A
    Clin Exp Pharmacol Physiol; 1998 May; 25(5):379-81. PubMed ID: 9612666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 3A4 activity after surgical stress.
    Haas CE; Kaufman DC; Jones CE; Burstein AH; Reiss W
    Crit Care Med; 2003 May; 31(5):1338-46. PubMed ID: 12771600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P450 3A activity and cyclosporine dosing in kidney and heart transplant recipients.
    Turgeon DK; Leichtman AB; Lown KS; Normolle DP; Deeb GM; Merion RM; Watkins PB
    Clin Pharmacol Ther; 1994 Sep; 56(3):253-60. PubMed ID: 7924120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian variation of the urinary 6beta-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity.
    Ohno M; Yamaguchi I; Ito T; Saiki K; Yamamoto I; Azuma J
    Eur J Clin Pharmacol; 2000; 55(11-12):861-5. PubMed ID: 10805065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythromycin breath test.
    Watkins PB
    Clin Pharmacol Ther; 2000 May; 67(5):577-8. PubMed ID: 10824637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.